Xtandi 40 MG capsule 120S
Ended Awarded
- Contract number
- SPE2DR26FCYV8
- Awardee
-
DMS Pharmaceutical Group Inc. UEI PX72BSBQTKJ3
- Awarding agency
-
Defense Logistics Agency
Department of Defense
- Obligated
- $17,021
Award facts
- Contract value 100% obligated
- $17,021.36 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 424210 Drugs and Druggists' Sundries Merchant Wholesalers
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Full and Open Competition Negotiated Proposal / Quote
- Pricing
- Firm Fixed Price
- Place of performance
- Park Ridge, IL 60068, USA
Award details come from SAM.gov/FPDS.
About this award
The Defense Logistics Agency awarded a $17,021.36 firm fixed-price delivery order for Xtandi 40 mg capsules (120-count) to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler headquartered in Park Ridge, Illinois. This delivery order, issued on November 12, 2025, with completion targeted for November 13, 2025, carries no set-aside designation, indicating the award was made through unrestricted federal competition. DMS Pharmaceutical Group is the sole contractor on this award with no identified subcontractors.
This delivery order is issued under DMS Pharmaceutical Group's single-award Indefinite Delivery Contract with the Defense Logistics Agency's Pharmaceutical Prime Vendor Global Program Generation V (PPV-G GEN V) initiative, which was established on November 13, 2025, with a $500 million ceiling value extending through December 31, 2036. The PPV-G GEN V program represents a $30.3 billion acquisition strategy designed to provide comprehensive pharmaceutical and medical supply support to Department of Defense healthcare facilities worldwide. The Xtandi supply fulfills recurring medication needs for military medical operations, consistent with DMS Pharmaceutical Group's demonstrated performance across a diverse portfolio of oncology treatments, specialty pharmaceuticals, biologics, and routine medications supplied to federal agencies.
Quick answers
Who was awarded contract SPE2DR26FCYV8?
SPE2DR26FCYV8 was awarded to DMS Pharmaceutical Group Inc. by Defense Logistics Agency (Department of Defense) on November 12, 2025.
How much is contract SPE2DR26FCYV8 worth?
The government has obligated $17,021 on SPE2DR26FCYV8.
Is contract SPE2DR26FCYV8 an order under another contract?
Yes. SPE2DR26FCYV8 is a delivery order under SPE2DR25D9127, an indefinite delivery contract.
Was contract SPE2DR26FCYV8 competed?
The extent of competition for SPE2DR26FCYV8 was full and open competition.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award